Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD

NCT03228121 is registered in ClinicalTrials.gov with Lung Institute as lead sponsor.

NCT NCT03228121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03228121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD
Lead sponsor
Lung Institute
Phase
Not applicable
Overall status
Withdrawn
Start date
April 24, 2017
Completion date
September 11, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis, copd, emphysema or copd